| Entry |
|
| Name |
Homatropine hydrobromide (JP16/USP);
Isopto homatropine (TN)
|
| Product |
|
| Other |
|
| Formula |
C16H21NO3. HBr
|
| Exact mass |
355.0783
|
| Mol weight |
356.2548
|
| Structure |

     |
| Activity |
Anticholinergic [ophthalmic]
|
| Remark |
Therapeutic category: ATC code: |
| Target |
|
| Pathway |
|
| Interaction |
|
| Structure map |
| Cholinergic and anticholinergic drugs |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
13 Agents affecting sensory organs
131 Ophthalmic agents
1311 Mydriatic agents
D01004 Homatropine hydrobromide (JP16/USP)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01F MYDRIATICS AND CYCLOPLEGICS
S01FA Anticholinergics
S01FA05 Homatropine
D01004 Homatropine hydrobromide (JP16/USP)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
muscarinic cholinergic receptor [HSA:1128 1129 1131 1132 1133] [KO:K04129 K04130 K04131 K04132 K04133]
Homatropine [ATC:S01FA05]
D01004 Homatropine hydrobromide (JP16/USP)
 |
| Other DBs |
CAS: 51-56-9 PubChem: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 21
1 X Br 35.9441 -16.6432
2 C1x C 26.0638 -19.5108
3 C1x C 26.3919 -18.3391
4 C1y C 27.2355 -19.2296
5 C1y C 27.5636 -18.0579
6 N1y N 26.2982 -16.7456
7 C1x C 29.1102 -19.2296
8 C1x C 28.8290 -18.0579
9 C1y C 30.1413 -19.7920
10 O7a O 31.2193 -20.6825
11 C7a C 32.4379 -20.6825
12 C1c C 33.0472 -19.6045
13 O6a O 33.0472 -21.8073
14 C8y C 34.2658 -19.6045
15 O1a O 32.4379 -18.5734
16 C8x C 34.9720 -20.8282
17 C8x C 36.3720 -20.8285
18 C8x C 37.0722 -19.6162
19 C8x C 36.3661 -18.3925
20 C8x C 34.9661 -18.3922
21 C1a C 25.5491 -15.5614
BOND 22
1 2 3 1
2 2 4 1
3 3 5 1
4 4 6 1
5 4 7 1
6 5 8 1
7 7 9 1
8 9 10 1 #Down
9 10 11 1
10 11 12 1
11 11 13 2
12 12 14 1
13 12 15 1
14 5 6 1
15 8 9 1
16 14 16 2
17 16 17 1
18 17 18 2
19 18 19 1
20 19 20 2
21 14 20 1
22 6 21 1
|